Table 6 Unadjusted and adjusted ORs for outcome (mortality and readmission) among women compared with men
| Men/Women (%) | Gender differences | ||||
| Unadjusted OR (95% CI) | OR adjusted for age (95% CI) | Adjusted OR, patients with LVSD only, n = 3584 (95% CI)† | Adjusted OR, patients with PLVF only, n = 2396 (95% CI)† | ||
| 12-week mortality | 12.7/15.2 | 1.24 (1.10 to 1.39) | 0.97 (0.86 to 1.10) | 1.10 (0.88 to 1.38) | 1.23 (0.93 to 1.64) |
| Readmissions during 12-week follow-up period | 20.3/18.9 | 0.92 (0.83 to 1.02) | 0.92 (0.82 to 1.02) | 1.03 (0.86 to 1.23) | 0.86 (0.70 to 1.05) |
-
*OR >1 correlates with a higher prevalence in women.
-
†Adjusted for age, hypertension, diabetes, stroke or transient ischaemic attack (TIA), renal failure, respiratory disease, coronary artery disease, cardiomyopathy, and atrial fibrillation.
